Dr Amy Cheung is a Senior Clinical Pharmacometrician in Quantitative Clinical Pharmacology and project manager of AstraZeneca Paediatric Working Group. She obtained a 1st-class honours degree in engineering at University of Warwick and a doctorate from the School of Pharmacy and Pharmaceutical Sciences, University of Manchester. She has experience in supporting drug development programmes on clinical trial design and modelling and simulation (phase 1-3), established brands in oncology and other TAs. Her research focuses oncology, paediatric, geriatric, structural identifiability and PBPK. She sits in paediatric group in Simcyp consortium, EFPIA Model Informed Drug Discovery and Development working group and IQ-CPLG-Pediatric Working Group.